- Home
- ABOS vs NNOX Comparison
ABOS vs NNOX Comparison
Compare ABOS & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | NNOX |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.7M | 155.6M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABOS | NNOX |
|---|---|---|
| Price | $2.86 | $2.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.00 | $5.00 |
| AVG Volume (30 Days) | 511.6K | ★ 970.0K |
| Earning Date | 05-12-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.19 |
| Revenue Next Year | N/A | $137.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.95 | $2.11 |
| 52 Week High | $3.60 | $5.72 |
Technical Indicators
Market Signals| Indicator | ABOS | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 57.09 | 41.47 |
| Support Level | $2.19 | $2.11 |
| Resistance Level | $3.05 | $2.66 |
| Average True Range (ATR) | 0.17 | 0.16 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 86.15 | 8.47 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.